Person: OKTAR, FAİK NÜZHET
Loading...
Email Address
Birth Date
Research Projects
Organizational Units
Job Title
Last Name
OKTAR
First Name
FAİK NÜZHET
Name
3 results
Search Results
Now showing 1 - 3 of 3
Publication Metadata only Design and characterization of polycaprolactone-gelatin-graphene oxide scaffolds for drug influence on glioblastoma cells(PERGAMON-ELSEVIER SCIENCE LTD, 2019) ATASOY, BESTE MELEK; Unal, Semra; Arslan, Sema; Gokce, Tilbe; Atasoy, Beste Melek; Karademir, Betul; Oktar, Faik Nuzhet; Gunduz, OguzhanThree-dimensional (3D) scaffolds that mimic in vivo tumor microenvironments can be used to study tumor response to anticancer treatments, since most preclinical combination treatment strategy for anti-glioma were evaluated with traditional 2D cell culture. In this research, the nanofiber scaffolds of polycaprolactone (PCL) containing gelatin (Gel) nano/microparticles coated with different concentrations of graphene oxide (GO) and were successfully produced by combining electrospinning and electrospraying techniques. Scanning electron microscope (SEM), Fourier-transform infrared (FT-IR) spectroscopy and mechanical testing were used to characterize the structure and properties of the composites. The results show that gelatin and graphene particles can be well dispersed in the polycaprolactone nanofiber matrix by using the combination technique of electrospinning and electrospraying. The presence of 1 wt% graphene oxide increased mechanical strength of PCL/Gel scaffold and was found to be well consistent with the drug treatments (temozolomide and bortezomib) and radiotherapy by not showing additional toxicity.Publication Metadata only Effects of Polymethylsilsesquioxane concentration on morphology shape of electrosprayed particles(ELSEVIER SCIENCE BV, 2018) OKTAR, FAİK NÜZHET; Unal, Semra; Oktar, Faik Nuzhet; Gunduz, OguzhanThe investigation of unique sizes and shapes as they relate to various properties has become a great study for large field applications. Polymethylsilsesquioxane (PMSQ) particles are produced by electrospraying. Morphology of the electrosprayed particles develops from the needle-like to star-like particles by controlling the concentration of the polymer solution. Therefore, electrospraying process instead of conventional methods has opened up an alternative for the fabrication of particles by controlling with three main parameters (applied voltage, flow rate and concentration of the polymer) that are used to manipulate their morphologies during preparation. (C) 2018 Elsevier B.V. All rights reserved.Publication Metadata only Encapsulated melatonin in polycaprolactone (PCL) microparticles as a promising graft material(ELSEVIER SCIENCE BV, 2019) ÖZBEYLİ, DİLEK; Gurler, Esra Bihter; Ergul, Necdet Mekki; Ozbek, Burak; Ekren, Nazmi; Oktar, Faik Nuzhet; Haskoylu, Merve Erginer; Oner, Ebru Toksoy; Eroglu, Mehmet Sayip; Ozbeyli, Dilek; Korkut, Veysel; Temiz, Ahmet Furkan; Kocanali, Nil; Gungordu, Rosa Juvan; Kilickan, Duhan Berkan; Gunduz, OguzhanElectrospraying assures many advantages with taking less time and costing less relatively to the other conventional particle production methods. In this research, we investigated the encapsulation of melatonin (MEL) hormone in polycaprolactone (PCL) microparticles by using electrospraying method. Morphology analysis of the produced particles completed with Scanning Electron Microscopy (SEM). SEM images demonstrated that microparticles of 3 wt% PCL solution has the most suitable particle diameter size (2.3 +/- 0.64 mu m) for melatonin encapsulation. According to the characterization of the particles, electrospraying parameters like optimal collecting distance, the flow rate of the solution and voltage of the system detected as 8 cm, 0.5 ml/h, and 10 kV respectively. For determining the chemical bonds of scaffold Fourier-Transform Infrared Spectroscopy (FTIR) were used and FTIR results showed that melatonin successfully loaded into PCL micro-particles. Drug release kinetics of the melatonin loaded particles indicated that melatonin released with a burst at the beginning and release behavior became sustainable over a period of 8 h with the encapsulation efficiency of about 73%. In addition, both in-vitro and in-vivo studies of the graft materials also completed. Primary human osteoblasts (HOB) cells and female Sprague Dawley rats were used in in-vitro and in-vivo studies. Test results demonstrate cell population, and bone volume of the rats grafted with composites has remarkably increased, this caused remodelling in bone structure. Overall, these findings indicate that encapsulation of melatonin in the PCL particles with electrospray method is optimum for new synthetic graft material.